Andrew Penkethman – CEO & Managing Director – Ardea Resources (ASX:ARL) is an ASX-listed nickel resources company, with a large portfolio of 100%-controlled West Australian-based projects.
Copyright 2024 – Finance News Network
Source: Finance News Network
11 Mar 2021 - Rural Funds Group Limited (ASX:RFF) General Manager - Investor Relations and Marketing, James Powell, presents on the group's HY21 results.
Read More31 Aug 2021 - VRX Silica Limited (ASX:VRX) Managing Director Bruce Maluish provides an update on the company's Arrowsmith and Muchea silica sand projects, potential offtake partners and financing.
Read More20 Nov 2023 - Dotz Nano (ASX:DTZ) navigates global challenges, focusing on carbon capture tech after strategic acquisitions and collaborations. CEO Sharon Malka discusses their resilient approach and plans for growth.
Read More20 Jul 2020 - BluGlass Limited (ASX:BLG) Managing Director and CEO Giles Bourne gives an update on the commissioning of the BLG 500 at Silverwater, strategic alliances and product roadmap.
Read More07 Jul 2021 - Knosys Limited (ASX:KNO Managing Director John Thompson provides an overview of the recent acquisition of LIBERO, a leading library management software business.
Read More10 Oct 2023 - Cameron Perks - Principal Analyst - Benchmark’s prices and data empowers clients: from critical mineral contracts to EV battery supply chain investments and government policy.
Read More12 Mar 2025 - The launch of Sofdra and what's next for Botanix
Read More30 Jul 2024 - Cristian Moreno - Managing Director - Torque Metals (ASX:TOR) is an exploration company with a proven discovery methodology, combining drilling results with machine learning algorithms and geological interpretation.
Read More23 Apr 2025 - The road to commercialisation: Overcoming funding and regulatory hurdles in battery storage
Read More10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
Read More
